Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy

Richard Mwaiswelo and Bill Ngasala
Malaria Journal 19 (1) (2020)
https://doi.org/10.1186/s12936-020-03235-3

Synthesis of Novel G Factor or Chloroquine-Artemisinin Hybrids and Conjugates with Potent Antiplasmodial Activity

Dionissia A. Pepe, Dimitra Toumpa, Christiane André-Barrès, et al.
ACS Medicinal Chemistry Letters 11 (5) 921 (2020)
https://doi.org/10.1021/acsmedchemlett.9b00669

Post-Marketing Surveillance of Quality of Artemether Injection Marketed in Southwest Nigeria

Ibrahim A. Hassan, Adebanjo J. Adegbola, Julius O. Soyinka, Cyprian O. Onyeji and Oluseye O. Bolaji
The American Journal of Tropical Medicine and Hygiene 103 (3) 1258 (2020)
https://doi.org/10.4269/ajtmh.20-0190

Plasmodium falciparum genetic factors rather than host factors are likely to drive resistance to ACT in Ghana

Peter Hodoameda, Nancy Odurowah Duah-Quashie, Charles Oheneba Hagan, et al.
Malaria Journal 19 (1) (2020)
https://doi.org/10.1186/s12936-020-03320-7

Nonclinical safety, tolerance and pharmacodynamics evaluation for meplazumab treating chloroquine-resistant Plasmodium falciparum

Kun Zhang, Yu Zhao, Zheng Zhang, et al.
Acta Pharmaceutica Sinica B 10 (9) 1680 (2020)
https://doi.org/10.1016/j.apsb.2020.06.011

Potentin vivoantimalarial activity of water-soluble artemisinin nano-preparations

Praveesh Valissery, Roshni Thapa, Jyoti Singh, et al.
RSC Advances 10 (59) 36201 (2020)
https://doi.org/10.1039/D0RA05597B

Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania

Manase Kilonzi, Omary Minzi, Ritah Mutagonda, et al.
Malaria Journal 19 (1) (2020)
https://doi.org/10.1186/s12936-020-3150-y

Enhancing the antimalarial activity of artesunate

J. O. Adebayo, H. Tijjani, A. P. Adegunloye, A. A. Ishola, E. A. Balogun and S. O. Malomo
Parasitology Research 119 (9) 2749 (2020)
https://doi.org/10.1007/s00436-020-06786-1

Vital role forPlasmodium bergheiKinesin8B in axoneme assembly during male gamete formation and mosquito transmission

Delphine Depoix, Sara Rute Marques, David JP Ferguson, et al.
Cellular Microbiology 22 (3) (2020)
https://doi.org/10.1111/cmi.13121

Discovery of 6′-chloro-N-methyl-5’-(phenylsulfonamido)-[3,3′-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium

Xiaofei Liang, Zongru Jiang, Zhenghui Huang, et al.
European Journal of Medicinal Chemistry 188 112012 (2020)
https://doi.org/10.1016/j.ejmech.2019.112012

Ethnopharmacology-aided antiplasmodial evaluation of six selected plants used for malaria treatment in Nigeria

I.C. Ezenyi, V. Verma, S. Singh, S.E. Okhale and B. Adzu
Journal of Ethnopharmacology 254 112694 (2020)
https://doi.org/10.1016/j.jep.2020.112694

Hybrid Gold(I) NHC-Artemether Complexes to Target Falciparum Malaria Parasites

Manel Ouji, Guillaume Barnoin, Álvaro Fernández Álvarez, Jean-Michel Augereau, Catherine Hemmert, Françoise Benoit-Vical and Heinz Gornitzka
Molecules 25 (12) 2817 (2020)
https://doi.org/10.3390/molecules25122817

Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia

Kristina Kesely, Panae Noomuna, Michal Vieth, et al.
PLOS ONE 15 (11) e0242372 (2020)
https://doi.org/10.1371/journal.pone.0242372

Bioactive Compounds, Pharmacological Actions, and Pharmacokinetics of Wormwood (Artemisia absinthium)

Gaber El-Saber Batiha, Ahmed Olatunde, Amany El-Mleeh, Helal F. Hetta, Salim Al-Rejaie, Saad Alghamdi, Muhammad Zahoor, Amany Magdy Beshbishy, Toshihiro Murata, Adrian Zaragoza-Bastida and Nallely Rivero-Perez
Antibiotics 9 (6) 353 (2020)
https://doi.org/10.3390/antibiotics9060353

Fungal Metabolite Asperaculane B Inhibits Malaria Infection and Transmission

Guodong Niu, Yue Hao, Xiaohong Wang, Jin-Ming Gao and Jun Li
Molecules 25 (13) 3018 (2020)
https://doi.org/10.3390/molecules25133018

Socio-demographic characteristics of the association between knowledge of antibiotic therapy and prudent use in Ghana

Tamara Jimah and Oladele Ogunseitan
Journal of Global Health Reports 4 (2020)
https://doi.org/10.29392/001c.12838

Antagonistic effects of some commonly used herbs on the efficacy of Artemisinin derivatives in the treatment of malaria in experimental mice

O. A. Idowu, A. S. Babalola and J. Olukunle
Bulletin of the National Research Centre 44 (1) (2020)
https://doi.org/10.1186/s42269-020-00429-2

Antimalarial stewardship programs are urgently needed for malaria elimination: a perspective

Anne-Lise Bienvenu, Abdoulaye Djimdé and Stéphane Picot
Parasite 26 16 (2019)
https://doi.org/10.1051/parasite/2019016

Investigating the comparative effects of six artemisinin-based combination therapies on Plasmodium-induced hepatorenal toxicity

InnocentA Edagha, AritJ Ekpo, EdelungudiI Edagha, JoyV Bassey, TitusP Nyong, AnthonyS Akpan, RoseF Obeten, AnthonyS Okon and BlessingA Ating
Nigerian Medical Journal 60 (4) 211 (2019)
https://doi.org/10.4103/nmj.NMJ_152_18

Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria

Yobouet Ines Kouakou, Michel Tod, Gilles Leboucher, et al.
International Journal of Infectious Diseases 89 30 (2019)
https://doi.org/10.1016/j.ijid.2019.08.030

Global Catastrophic Biological Risks

Emily Ricotta and Jennifer Kwan
Current Topics in Microbiology and Immunology, Global Catastrophic Biological Risks 424 33 (2019)
https://doi.org/10.1007/82_2019_163

Winning the Tug-of-War Between Effector Gene Design and Pathogen Evolution in Vector Population Replacement Strategies

John M. Marshall, Robyn R. Raban, Nikolay P. Kandul, et al.
Frontiers in Genetics 10 (2019)
https://doi.org/10.3389/fgene.2019.01072

Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes

Bénédicte Gnangnon, Aline Fréville, Katia Cailliau, et al.
Scientific Reports 9 (1) (2019)
https://doi.org/10.1038/s41598-019-44542-3

Plasmodium Genomics and Genetics: New Insights into Malaria Pathogenesis, Drug Resistance, Epidemiology, and Evolution

Xin-zhuan Su, Kristin D. Lane, Lu Xia, Juliana M. Sá and Thomas E. Wellems
Clinical Microbiology Reviews 32 (4) (2019)
https://doi.org/10.1128/CMR.00019-19

Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome Inhibitors

Wenhu Zhan, Joseph Visone, Tierra Ouellette, et al.
Journal of Medicinal Chemistry 62 (13) 6137 (2019)
https://doi.org/10.1021/acs.jmedchem.9b00363

Gene silencing through RNAi and antisense Vivo-Morpholino increases the efficacy of pyrethroids on larvae of Anopheles stephensi

Agata Negri, Marco Ferrari, Riccardo Nodari, et al.
Malaria Journal 18 (1) (2019)
https://doi.org/10.1186/s12936-019-2925-5

Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties

Aissata Camara, Mohamed Haddad, Karine Reybier, et al.
Malaria Journal 18 (1) (2019)
https://doi.org/10.1186/s12936-019-3071-9

Isoxazolopyrimidine-Based Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Antimalarial Activity

Sreekanth Kokkonda, Farah El Mazouni, Karen L. White, et al.
ACS Omega 3 (8) 9227 (2018)
https://doi.org/10.1021/acsomega.8b01573

Status of Artemisinin Resistance in Malaria Parasite Plasmodium falciparum from Molecular Analyses of the Kelch13 Gene in Southwestern Nigeria

Mary Aigbiremo Oboh, Daouda Ndiaye, Hiasindh Ashmi Antony, et al.
BioMed Research International 2018 1 (2018)
https://doi.org/10.1155/2018/2305062

The  early  preclinical and clinical development of ganaplacide (KAF156), a novel antimalarial compound

Robin Koller, Ghyslain Mombo-Ngoma and Martin P. Grobusch
Expert Opinion on Investigational Drugs 27 (10) 803 (2018)
https://doi.org/10.1080/13543784.2018.1524871